SYNTHELIS

Synthelis is attending #BIOEurope!   Join us in Stockholm, Sweden, November 4–6, 2024, to connect and celebrate the event's 30th anniversary. Registration information: https://bit.ly/4biIK0G   See you in Stockholm?   #Cellfree #Congress #BIOEurope #Partnering

🎤 2nd day ay #iGEMGrandJamboree 🎬 ! Bruno Tillier had the opportunity to pitch today and Vincent Poher was interviewed about our cell-free technology. Come by our kiosk and talk to us about how cell-free can help you speed up your projects. 🚀 💥 A busy but exciting day at SYNTHELIS #Pitch #Interview #iGEM #Startup #Biotech #Innovation #Cellfree

🎤 Back from a fascinating scientific conference: #ncAAs2024 in Paris!   Dr Marion Gransagne had the opportunity to attend cutting-edge presentations on protein synthesis and amino acid engineering.   Among the speakers: 🔬 Klara Hlouchova explored the origin of amino acids and asked an intriguing question: Why was this specific set of 20 amino acids selected by evolution? And more importantly, could we replace it with a different set?   🧬 Jason Chin impressed us with his complete reprogramming of a bacterium. He modified all redundant serine codons, leaving only one. The remaining codons are now used to insert non-natural amino acids—a major leap forward for bioengineering!   🧪 Benjamin Davis discussed the complexity of protein glycosylation, a key area in developing therapeutic proteins.   These advancements open up new perspectives in biotechnology and cell-free synthesis. 🚀✨ Thank you to GFPP (Groupe Français des Peptides et Protéines) for this insightful meeting!   #biotech #cellfree #aminoacids #proteinsynthesis #innovation #geneticengineering #conference  

📢 Meet the Experts at iGEM Grand Jamboree 2024! 🔬✨ We’re excited to announce that Vincent Poher and Bruno Tillier will be at our booth at the iGEM Competition Grand Jamboree, ready to discuss the future of biosynthesis! 🧬 Whether you're interested in the latest advancements in synthetic biology or exploring new solutions in biosynthesis, stop by to chat with our experts and discover how Synthelis Biotech is shaping the future of this exciting field. Come join the conversation—we’d love to connect! 👋 #iGEM2024 #Biosynthesis #SynBio #FutureOfBiotech #Innovation #Synthelis #MeetTheExperts

🚀 Exciting News! 🚀 Next week, Synthelis Biotech will be exhibiting at the iGEM Grand Jamboree 2024, the premier event in Synthetic Biology! 🌍🔬   Join us in Paris from the 23rd to the 26th of October to witness the future and interact with tomorrow's leaders of Synthetic Biology. This event gathers researchers, industry experts, startup founders, investors, policymakers, journalists, and the public to shape the future of this cutting-edge field.   We’re thrilled to showcase our latest innovations in cell-free technology, and we can't wait to connect with all the incredible minds pushing the boundaries of science. See you at iGEM! 💡✨   #iGEM2024 #SyntheticBiology #Innovation #FutureOfBiotech #CompanyX #SynBio  

We're looking forward to attending the 2nd edition of the "Noncanonical Amino Acids (ncAAs): Tools for Biological and Biophysical Investigations" meeting in Paris on October 14th and 15th, 2024.   Jointly organized by Sorbonne Université and CY Cergy Paris Université, in partnership with GFPP (Groupe Français des Peptides et Protéines), this conference will gather up to 150 participants, including leading chemists and biologists from both public and private sectors.   We’re particularly excited to see young scientists take the stage, present their innovative research, and have insightful discussions about the future of protein synthesis.   Don’t miss the opportunity to meet Dr. Marion Gransagne, Synthelis R&D Scientist to talk about your projects!    #ncAA2024 #biochemistry #noncanonicalaminoacids #research #scienceconference #youngscientists #innovation

🌟 Innovations in Drug Development: The Role of Cell-Free Protein Synthesis🌟 Discover in this article how cell-free protein synthesis (CFPS) is reshaping the future of drug development and manufacturing. By bypassing the need for living cells, CFPS enables faster, scalable production of complex proteins. This technology holds promise in reducing costs, speeding up R&D timelines, and enhancing precision in personalized medicine. As the demand for innovative biologics grows, CFPS could be a game changer for the pharmaceutical industry. 🌍💊   Our in-house experts can provide you with the support you need to make the right choice and obtain the highest yield of proteins using CFPS.   We would like to thank Cynthia Challener for using some of our blog posts as a source for this article. https://lnkd.in/dhNgFpCd   #DrugDevelopment #Innovation #Biotechnology #CFPS #Cellfree

💡 Curious about how our technology is transforming the way we develop biopharmaceuticals? 👉🏻 Swipe through our carousel below to discover how Cell-Free systems are accelerating the production of life-saving therapies with unmatched speed, flexibility, and safety. 🚀 #BiotechInnovation #CellFree #Pharma

🌞 We’re Here All Summer! 🌞 Synthelis will remain open throughout the entire summer season! Our dedicated team is fully committed and mobilized to meet all our clients' needs. Whether you're planning a new CFPS project or need ongoing support, you can count on us to be here, ready to assist you. Thank you for your continued trust and partnership. Let’s make this summer productive and successful together! #Summer2024 #AlwaysOpen #CustomerSupport #TeamX #WeAreHereForYou #Cellfree

Membrane proteins (MPs) are critical to various cellular processes, yet their native complexity hinders functional studies. Enter cell-free systems, allowing MPs to be expressed, purified and reconstituted into liposomes, creating proteoliposomes for detailed analysis. 🔬 Why are Proteoliposomes a Game-Changer? -      Innovative Drug Delivery: proteoliposomes show promise as drug delivery systems, efficiently carrying both hydrophilic and hydrophobic drugs, potentially transforming therapeutic approaches. -      Advanced Structural Studies: proteoliposomes facilitate NMR-based structure determination of MPs in their proper folding, crucial for understanding protein functions and developing targeted treatments. With more than 13 years of experience in cell-free technology and membrane protein expression, Synthelis can produce functional and oriented membrane proteins in proteoliposome format using either its patented approach to directly incorporate the protein target into the lipid bilayer of the liposomes, or after protein solubilization and purification followed by a relipidation phase. Discover our new Blog Post here : https://lnkd.in/gjSRnDzT Embrace the future of MP research with cell-free systems and proteoliposomes, driving breakthroughs in drug delivery, structural studies, and beyond! 🌐🔬 #DrugDelivery #MembraneProteins #BiotechInnovation #CellFreeSystems #Proteoliposomes #ResearchAdvancement